Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Visual outcome after antioxidant supplementation.

Beatty S, Nolan JM, Muldrew KA, Woodside J, Stevenson MR, Chakravarthy U.

Ophthalmology. 2013 Mar;120(3):645. doi: 10.1016/j.ophtha.2012.09.013. No abstract available.

PMID:
23714607
2.

Secondary outcomes in a clinical trial of carotenoids with coantioxidants versus placebo in early age-related macular degeneration.

Beatty S, Chakravarthy U, Nolan JM, Muldrew KA, Woodside JV, Denny F, Stevenson MR.

Ophthalmology. 2013 Mar;120(3):600-6. doi: 10.1016/j.ophtha.2012.08.040. Epub 2012 Dec 6.

PMID:
23218821
3.

Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.

Age-Related Eye Disease Study 2 (AREDS2) Research Group, Chew EY, Clemons TE, Sangiovanni JP, Danis RP, Ferris FL 3rd, Elman MJ, Antoszyk AN, Ruby AJ, Orth D, Bressler SB, Fish GE, Hubbard GB, Klein ML, Chandra SR, Blodi BA, Domalpally A, Friberg T, Wong WT, Rosenfeld PJ, Agrón E, Toth CA, Bernstein PS, Sperduto RD.

JAMA Ophthalmol. 2014 Feb;132(2):142-9. doi: 10.1001/jamaophthalmol.2013.7376.

5.

Functional and morphologic benefits in early detection of neovascular age-related macular degeneration using the preferential hyperacuity perimeter.

Lai Y, Grattan J, Shi Y, Young G, Muldrew A, Chakravarthy U.

Retina. 2011 Sep;31(8):1620-6. doi: 10.1097/IAE.0b013e31820d3ed1.

PMID:
21610564
6.

Evidence for including lutein and zeaxanthin in oral supplements for age-related macular degeneration.

Musch DC.

JAMA Ophthalmol. 2014 Feb;132(2):139-41. doi: 10.1001/jamaophthalmol.2013.7443. No abstract available.

PMID:
24309835
7.
8.

Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration.

Benke KK, Benke KE.

JAMA Ophthalmol. 2014 Jul;132(7):904. doi: 10.1001/jamaophthalmol.2014.1768. No abstract available.

PMID:
25010177
9.

Experimental design issue for assessment of carotenoids lutein and zeaxanthin in age-related eye disease study 2 formulation for age-related macular degeneration--reply.

Chew EY, Clemons TE.

JAMA Ophthalmol. 2014 Jul;132(7):904-5. doi: 10.1001/jamaophthalmol.2014.1783. No abstract available.

PMID:
25010178
10.

Beneficial long-term effects of combined oral/topical antioxidant treatment with the carotenoids lutein and zeaxanthin on human skin: a double-blind, placebo-controlled study.

Palombo P, Fabrizi G, Ruocco V, Ruocco E, Fluhr J, Roberts R, Morganti P.

Skin Pharmacol Physiol. 2007;20(4):199-210. Epub 2007 Apr 19.

11.

Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial.

Downie LE, Keller PR.

JAMA Ophthalmol. 2014 Aug;132(8):1031. doi: 10.1001/jamaophthalmol.2014.2007. No abstract available.

PMID:
25124957
12.

Making sense of the evidence from the age-related eye disease study 2 randomized clinical trial-reply.

Chew EY, Clemons TE.

JAMA Ophthalmol. 2014 Aug;132(8):1031-2. doi: 10.1001/jamaophthalmol.2014.2009. No abstract available.

PMID:
25124958
13.

Carotenoids in Age-related Maculopathy Italian Study (CARMIS): two-year results of a randomized study.

Piermarocchi S, Saviano S, Parisi V, Tedeschi M, Panozzo G, Scarpa G, Boschi G, Lo Giudice G; Carmis Study Group.

Eur J Ophthalmol. 2012 Mar-Apr;22(2):216-25. doi: 10.5301/ejo.5000069.

PMID:
22009916
14.

Influence of short-term antioxidant supplementation on macular function in age-related maculopathy: a pilot study including electrophysiologic assessment.

Falsini B, Piccardi M, Iarossi G, Fadda A, Merendino E, Valentini P.

Ophthalmology. 2003 Jan;110(1):51-60; discussion 61.

PMID:
12511345
16.

Carotenoids and antioxidants in age-related maculopathy italian study: multifocal electroretinogram modifications after 1 year.

Parisi V, Tedeschi M, Gallinaro G, Varano M, Saviano S, Piermarocchi S; CARMIS Study Group.

Ophthalmology. 2008 Feb;115(2):324-333.e2. Epub 2007 Aug 22.

PMID:
17716735
17.

Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography.

Manjunath V, Goren J, Fujimoto JG, Duker JS.

Am J Ophthalmol. 2011 Oct;152(4):663-8. doi: 10.1016/j.ajo.2011.03.008. Epub 2011 Jun 25.

18.

Electroretinographic effects of omega-3 Fatty Acid supplementation on dry age-related macular degeneration.

Gerstenblith AT, Baskin DE, Shah CP, Wolfe JD, Fineman MS, Kaiser RS, Ho AC.

JAMA Ophthalmol. 2013 Mar;131(3):365-9. doi: 10.1001/jamaophthalmol.2013.642.

PMID:
23494041
19.

Eating for good vision. Add these nutrients to your diet to preserve and protect your eyesight.

[No authors listed]

Harv Womens Health Watch. 2013 Oct;21(2):6. No abstract available.

PMID:
24432456
20.

Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD).

Tsika C, Tsilimbaris MK, Makridaki M, Kontadakis G, Plainis S, Moschandreas J.

Acta Ophthalmol. 2011 Nov;89(7):e573-8. doi: 10.1111/j.1755-3768.2011.02170.x. Epub 2011 Jun 15.

Supplemental Content

Support Center